目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 7 MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 8 MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF RECESSION ON MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 10 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
4.1 MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW
FIGURE 15 GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET, BY SERVICE AND COUNTRY (2023)
FIGURE 16 SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
4.3 NORTH AMERICA: MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing demand for metagenomic sequencing
5.2.1.2 Growing focus on human microbiome therapeutics development
FIGURE 19 ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT
5.2.1.3 High cost of advanced infrastructure for sequencing
TABLE 5 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled personnel
5.2.3 OPPORTUNITIES
5.2.3.1 Expanding applications of microbiome sequencing in therapeutics development
5.2.4 CHALLENGES
5.2.4.1 Issues related to sample preparation/isolation of microbes for sequencing
5.3 TECHNOLOGY ANALYSIS
5.4 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS OF MARKET
5.6 ECOSYSTEM MARKET MAP
FIGURE 22 ECOSYSTEM OF MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.1.2 Canada
5.8.2 EUROPE
5.8.3 ASIA PACIFIC
5.8.3.1 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.8.3.2 Japan
5.8.3.3 India
5.8.4 LATIN AMERICA
5.8.5 MIDDLE EAST
5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS
5.9 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE, BY SERVICE AND TYPE
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
5.10 KEY CONFERENCES AND EVENTS IN 2023-2024
TABLE 12 MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023-2024
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES
FIGURE 24 CRITERIA FOR OUTSOURCING SEQUENCING SERVICES

6 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE (Page No. - 73)
6.1 INTRODUCTION
TABLE 13 MARKET, BY SERVICE, 2021-2028 (USD MILLION)
6.2 SAMPLE PREPARATION
6.2.1 NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH
TABLE 14 MARKET FOR SAMPLE PREPARATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 15 NORTH AMERICA: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 16 EUROPE: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 18 LATIN AMERICA: MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 SEQUENCING AND LIBRARY PREPARATION
6.3.1 SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD
TABLE 19 MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021-2028 (USD MILLION)
TABLE 20 NORTH AMERICA: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 21 EUROPE: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 23 LATIN AMERICA: MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 DATA ANALYSIS
6.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH
TABLE 24 MARKET FOR DATA ANALYSIS, BY REGION, 2021-2028 (USD MILLION)
TABLE 25 NORTH AMERICA: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 26 EUROPE: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 LATIN AMERICA: MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)

7 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE (Page No. - 81)
7.1 INTRODUCTION
TABLE 29 MARKET, BY TYPE, 2021-2028 (USD MILLION)
7.2 AMPLICON SEQUENCING
7.2.1 HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION
TABLE 30 AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 31 NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 32 EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 WHOLE-GENOME SEQUENCING
7.3.1 ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET
TABLE 35 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 36 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 39 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
7.4 SHOTGUN SEQUENCING
7.4.1 ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION
TABLE 40 SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 41 NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
7.5 OTHER TYPES
TABLE 45 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 46 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 47 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY (Page No. - 91)
8.1 INTRODUCTION
TABLE 50 MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
8.2 SEQUENCING BY SYNTHESIS (SBS)
8.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME
TABLE 51 MARKET FOR SBS, BY REGION, 2021-2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 53 EUROPE: MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 LATIN AMERICA: MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
8.3 SEQUENCING BY LIGATION (SBL)
8.3.1 INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH
TABLE 56 MARKET FOR SBL, BY REGION, 2021-2028 (USD MILLION)
TABLE 57 NORTH AMERICA: MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 58 EUROPE: MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 ASIA PACIFIC: MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 LATIN AMERICA: MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
8.4 NANOPORE SEQUENCING
8.4.1 ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
TABLE 61 MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
TABLE 62 NORTH AMERICA: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 63 EUROPE: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 LATIN AMERICA: MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
8.5 OTHER TECHNOLOGIES
TABLE 66 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 68 EUROPE: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 70 LATIN AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER (Page No. - 101)
9.1 INTRODUCTION
TABLE 71 MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.2.1 ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET
TABLE 72 MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 74 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 76 LATIN AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
9.3 ACADEMIC AND RESEARCH INSTITUTES
9.3.1 EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH
TABLE 77 MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
TABLE 78 NORTH AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 79 EUROPE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 81 LATIN AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
9.4 OTHER END USERS
TABLE 82 MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 83 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 84 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 86 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION (Page No. - 110)
10.1 INTRODUCTION
FIGURE 25 MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
TABLE 87 MARKET, BY REGION, 2021-2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
TABLE 88 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing awareness of microbiome research to drive growth
TABLE 93 US: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 94 US: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 US: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 96 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing prevalence of chronic diseases to boost microbiome research
TABLE 97 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 98 CANADA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 99 CANADA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 100 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.3 NORTH AMERICA: IMPACT OF RECESSION
10.3 EUROPE
TABLE 101 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 102 EUROPE: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 103 EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 104 EUROPE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 105 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rapidly increasing government funding to support growth
TABLE 106 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 107 GERMANY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 108 GERMANY: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 109 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Significant government investments in genomics research to propel growth
TABLE 110 UK: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 111 UK: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 112 UK: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 113 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Growing number of microbiome sequencing startups to propel growth
TABLE 114 HUMAN MICROBIOME STARTUPS IN FRANCE
TABLE 115 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 116 FRANCE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 117 FRANCE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 118 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing use of microbiome services in clinical research to drive growth
TABLE 119 ITALY: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 120 ITALY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 121 ITALY: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 122 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing prevalence of chronic diseases to drive market
TABLE 123 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 124 SPAIN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 125 SPAIN: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 126 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 127 REST OF EUROPE: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 128 REST OF EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 129 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 130 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.7 EUROPE: IMPACT OF RECESSION
10.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
TABLE 131 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 135 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Increasing investments in R&D to drive growth
TABLE 136 CHINA: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 137 CHINA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 138 CHINA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 139 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Significant growth in geriatric population to present opportunities for market growth
TABLE 140 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 141 JAPAN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 142 JAPAN: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 143 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing prevalence of chronic diseases to support growth
TABLE 144 INDIA: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 145 INDIA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 146 INDIA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 147 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 148 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 149 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 150 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 151 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.5 ASIA PACIFIC: IMPACT OF RECESSION
10.5 LATIN AMERICA
TABLE 152 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 153 LATIN AMERICA: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 154 LATIN AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 155 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 156 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Growing adoption of next-generation sequencing technologies to propel growth
TABLE 157 BRAZIL: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 158 BRAZIL: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 159 BRAZIL: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 160 BRAZIL: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.2 REST OF LATIN AMERICA
TABLE 161 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 162 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 163 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 164 REST OF LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.3 LATIN AMERICA: IMPACT OF RECESSION
10.6 MIDDLE EAST & AFRICA
TABLE 165 MIDDLE EAST & AFRICA: MARKET, BY SERVICE, 2021-2028 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6.1 MIDDLE EAST & AFRICA: IMPACT OF RECESSION

11 COMPETITIVE LANDSCAPE (Page No. - 155)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 28 STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020-2023
11.3 MARKET SHARE ANALYSIS
FIGURE 29 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 169 MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MARKET, 2020-2022
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 31 MARKET: COMPANY EVALUATION QUADRANT, 2022
11.6 COMPETITIVE SCENARIO
TABLE 170 SERVICE LAUNCHES
TABLE 171 DEALS

12 COMPANY PROFILES (Page No. - 163)
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 CHARLES RIVER LABORATORIES
TABLE 172 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.2 EUROFINS SCIENTIFIC
TABLE 173 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
12.1.3 BGI GROUP
TABLE 174 BGI GROUP: BUSINESS OVERVIEW
12.1.4 COSMOSID
TABLE 175 COSMOSID: BUSINESS OVERVIEW
12.1.5 MICROBA
TABLE 176 MICROBA: BUSINESS OVERVIEW
12.1.6 QIAGEN N.V.
TABLE 177 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
12.1.7 MICROBIOME INSIGHTS
TABLE 178 MICROBIOME INSIGHTS: BUSINESS OVERVIEW
12.1.8 BASECLEAR
TABLE 179 BASECLEAR: BUSINESS OVERVIEW
12.1.9 CD GENOMICS
TABLE 180 CD GENOMICS: COMPANY OVERVIEW
12.1.10 ZYMO RESEARCH CORPORATION
TABLE 181 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
12.1.11 ORASURE TECHNOLOGIES
TABLE 182 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 35 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022)
12.1.12 MR DNA
TABLE 183 MR DNA: BUSINESS OVERVIEW
12.1.13 EREMID GENOMIC SERVICES
TABLE 184 EREMID GENOMIC SERVICES: BUSINESS OVERVIEW
12.1.14 CLINICAL-MICROBIOMICS A/S
TABLE 185 CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW
12.1.15 NOVOGENE CO., LTD.
TABLE 186 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 EZBIOME
12.2.2 BOSTER BIOLOGICAL TECHNOLOGY
12.2.3 ZIFO
12.2.4 OMICS2VIEW.CONSULTING GBR
12.2.5 MACROGEN, INC.

13 APPENDIX (Page No. - 194)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS